Baculovirus-Induced Fast-Acting Innate Immunity Kills Liver-Stage Plasmodium.
Talhah Bin EmranMitsuhiro IyoriYuki OnoFitri AmeliaYenni YusufAshekul IslamAsrar AlamMegumi TamuraRyohei OgawaHiroyuki MatsuokaDaisuke S YamamotoShigeto YoshidaPublished in: Journal of immunology (Baltimore, Md. : 1950) (2018)
Baculovirus (BV), an enveloped insect virus with a circular dsDNA genome, possesses unique characteristics that induce strong innate immune responses in mammalian cells. In this study, we show that BV administration in BALB/c mice not only provides complete protection against a subsequent Plasmodium berghei sporozoite infection for up to 7 d after the injection but also eliminates existing liver-stage parasites completely. The elimination of sporozoites by BV was superior to that by primaquine, and this effect occurred in a TLR9-independent manner. At 6 h after BV administration, IFN-α and IFN-γ were robustly produced in the serum, and RNA transcripts of IFN-stimulated genes were markedly upregulated in the liver compared with control mice. The in vivo passive transfer of serum after BV administration effectively eliminated liver-stage parasites, and IFN-α neutralization abolished this effect, indicating that the BV liver-stage parasite-killing mechanism is downstream of the type I IFN signaling pathway. These findings provide evidence that BV-induced, fast-acting innate immunity completely kills liver-stage parasites and, thus, may lead to new malaria drug and vaccine strategies.
Keyphrases
- immune response
- lps induced
- plasmodium falciparum
- lipopolysaccharide induced
- dendritic cells
- inflammatory response
- signaling pathway
- toll like receptor
- oxidative stress
- high glucose
- emergency department
- genome wide
- adipose tissue
- gene expression
- diabetic rats
- drug induced
- epithelial mesenchymal transition
- cell proliferation
- high fat diet induced
- pi k akt
- ultrasound guided
- adverse drug
- genome wide analysis